Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-02-20

AUTHORS

Andrzej T Slominski, Anna A Brożyna, Michal A Zmijewski, Wojciech Jóźwicki, Anton M Jetten, Rebecca S Mason, Robert C Tuckey, Craig A Elmets

ABSTRACT

Ultraviolet B (UVB), in addition to having carcinogenic activity, is required for the production of vitamin D3 (D3) in the skin which supplies >90% of the body’s requirement. Vitamin D is activated through hydroxylation by 25-hydroxylases (CYP2R1 or CYP27A1) and 1α-hydroxylase (CYP27B1) to produce 1,25(OH)2D3, or through the action of CYP11A1 to produce mono-di- and trihydroxy-D3 products that can be further modified by CYP27B1, CYP27A1, and CYP24A1. The active forms of D3, in addition to regulating calcium metabolism, exert pleiotropic activities, which include anticarcinogenic and anti-melanoma effects in experimental models, with photoprotection against UVB-induced damage. These diverse effects are mediated through an interaction with the vitamin D receptor (VDR) and/or as most recently demonstrated through action on retinoic acid orphan receptors (ROR)α and RORγ. With respect to melanoma, low levels of 25(OH)D are associated with thicker tumors and reduced patient survival. Furthermore, single-nucleotide polymorphisms of VDR and the vitamin D-binding protein (VDP) genes affect melanomagenesis or disease outcome. Clinicopathological analyses have shown positive correlation between low or undetectable expression of VDR and/or CYP27B1 in melanoma with tumor progression and shorter overall (OS) and disease-free survival (DFS) times. Paradoxically, this correlation was reversed for CYP24A1 (inactivating 24-hydroxylase), indicating that this enzyme, while inactivating 1,25(OH)2D3, can activate other forms of D3 that are products of the non-canonical pathway initiated by CYP11A1. An inverse correlation has been found between the levels of RORα and RORγ expression and melanoma progression and disease outcome. Therefore, we propose that defects in vitamin D signaling including D3 activation/inactivation, and the expression and activity of the corresponding receptors, affect melanoma progression and the outcome of the disease. The existence of multiple bioactive forms of D3 and alternative receptors affecting the behavior of melanoma should be taken into consideration when applying vitamin D management for melanoma therapy. More... »

PAGES

706-724

References to SciGraph publications

  • 2011-11-17. High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives in BRITISH JOURNAL OF CANCER
  • 2012-07-08. Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells in NATURE MEDICINE
  • 2009-06-20. Increased Levels of 25 Hydroxyvitamin D and 1,25-Dihydroxyvitamin D After Rosuvastatin Treatment: A Novel Pleiotropic Effect of Statins? in CARDIOVASCULAR DRUGS AND THERAPY
  • 2011-10-03. NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway in ONCOGENE
  • 2014-01-14. Melanoma—the run of success continues in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2011-08-17. Vitamin D and the skin: Physiology and pathophysiology in REVIEWS IN ENDOCRINE AND METABOLIC DISORDERS
  • 2013-02-16. Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona in BMC MEDICAL GENOMICS
  • 2009-01-20. Association between serum 25(OH)D and death from prostate cancer in BRITISH JOURNAL OF CANCER
  • 2014. Protection from Ultraviolet Damage and Photocarcinogenesis by Vitamin D Compounds in SUNLIGHT, VITAMIN D AND SKIN CANCER
  • 2009-11-05. Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review in MEDICAL ONCOLOGY
  • 2014-10-24. Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D) in BMC CANCER
  • 2013-02-18. Targeted therapy for melanoma: rational combinatorial approaches in ONCOGENE
  • 2010-12-01. Vitamin D, disease and therapeutic opportunities in NATURE REVIEWS DRUG DISCOVERY
  • 2015-10-08. Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland in SCIENTIFIC REPORTS
  • 2016-07-19. The Itch to degrade ROR-γt in NATURE IMMUNOLOGY
  • 2008-01-16. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells in BMC CANCER
  • 2007-09. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics in NATURE REVIEWS CANCER
  • 2005-09-23. Expression of VDR and CYP24A1 mRNA in human tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016-06-23. Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies in BRITISH JOURNAL OF CANCER
  • 1998-11-03. Differential apoptotic response of human melanoma cells to 1α,25-dihydroxyvitamin D3 and its analogues in CELL DEATH & DIFFERENTIATION
  • 2014-05-06. Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma in TUMOR BIOLOGY
  • 2011-09-02. A Switch Between Cytoprotective and Cytotoxic Autophagy in the Radiosensitization of Breast Tumor Cells by Chloroquine and Vitamin D in DISCOVER ONCOLOGY
  • 2000-11. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) in CANCER CAUSES & CONTROL
  • 2015-04-23. Melanoma in NATURE REVIEWS DISEASE PRIMERS
  • 2014-04-04. The role of vitamin D in reducing cancer risk and progression in NATURE REVIEWS CANCER
  • 2008-09-04. Synthesis and photo-conversion of androsta- and pregna-5,7-dienes to vitamin D3-like derivatives in PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
  • 2005-05-20. Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death in CELL DEATH & DIFFERENTIATION
  • 2012-12-21. 25-Hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment in CLINICAL RESEARCH IN CARDIOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/labinvest.2017.3

    DOI

    http://dx.doi.org/10.1038/labinvest.2017.3

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1083850727

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/28218743


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cytochrome P-450 Enzyme System", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease Progression", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Epidermis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Melanoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Calcitriol", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Signal Transduction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ultraviolet Rays", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vitamin D", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Pathology and Laboratory Medicine, VA Medical Center, Birmingham, AL, USA", 
              "id": "http://www.grid.ac/institutes/grid.280808.a", 
              "name": [
                "Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA", 
                "Comprehensive Cancer Center, Cancer Chemoprevention Program, and Nutrition Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL, USA", 
                "Pathology and Laboratory Medicine, VA Medical Center, Birmingham, AL, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Slominski", 
            "givenName": "Andrzej T", 
            "id": "sg:person.016612034677.24", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016612034677.24"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Tumor Pathology and Pathomorphology, Faculty of Health Sciences, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland", 
              "id": "http://www.grid.ac/institutes/grid.411797.d", 
              "name": [
                "Department of Tumor Pathology and Pathomorphology, Oncology Centre - Prof. Franciszek \u0141ukaszczyk Memorial Hospital, Bydgoszcz, Poland", 
                "Department of Tumor Pathology and Pathomorphology, Faculty of Health Sciences, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bro\u017cyna", 
            "givenName": "Anna A", 
            "id": "sg:person.01247433576.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247433576.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Histology, Medical University of Gda\u0144sk, Poland", 
              "id": "http://www.grid.ac/institutes/grid.11451.30", 
              "name": [
                "Department of Histology, Medical University of Gda\u0144sk, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zmijewski", 
            "givenName": "Michal A", 
            "id": "sg:person.01357647717.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357647717.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Tumor Pathology and Pathomorphology, Faculty of Health Sciences, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland", 
              "id": "http://www.grid.ac/institutes/grid.411797.d", 
              "name": [
                "Department of Tumor Pathology and Pathomorphology, Oncology Centre - Prof. Franciszek \u0141ukaszczyk Memorial Hospital, Bydgoszcz, Poland", 
                "Department of Tumor Pathology and Pathomorphology, Faculty of Health Sciences, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "J\u00f3\u017awicki", 
            "givenName": "Wojciech", 
            "id": "sg:person.01173540763.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173540763.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA", 
              "id": "http://www.grid.ac/institutes/grid.280664.e", 
              "name": [
                "Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jetten", 
            "givenName": "Anton M", 
            "id": "sg:person.0603130014.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603130014.84"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Bosch Institute and School of Medical Sciences, Sydney Medical School, The University of Sydney, Sydney, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1013.3", 
              "name": [
                "Bosch Institute and School of Medical Sciences, Sydney Medical School, The University of Sydney, Sydney, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mason", 
            "givenName": "Rebecca S", 
            "id": "sg:person.0771044716.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771044716.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "School of Chemistry and Biochemistry, The University of Western Australia, Crawley, Perth, WA, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1012.2", 
              "name": [
                "School of Chemistry and Biochemistry, The University of Western Australia, Crawley, Perth, WA, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tuckey", 
            "givenName": "Robert C", 
            "id": "sg:person.01205643625.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205643625.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Comprehensive Cancer Center, Cancer Chemoprevention Program, and Nutrition Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL, USA", 
              "id": "http://www.grid.ac/institutes/grid.265892.2", 
              "name": [
                "Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA", 
                "Comprehensive Cancer Center, Cancer Chemoprevention Program, and Nutrition Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Elmets", 
            "givenName": "Craig A", 
            "id": "sg:person.01213437447.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213437447.92"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/srep14875", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027641851", 
              "https://doi.org/10.1038/srep14875"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12032-009-9348-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016315086", 
              "https://doi.org/10.1007/s12032-009-9348-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc3691", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052056915", 
              "https://doi.org/10.1038/nrc3691"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1008923802001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030296825", 
              "https://doi.org/10.1023/a:1008923802001"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrdp.2015.3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045528904", 
              "https://doi.org/10.1038/nrdp.2015.3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.2011.458", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025567432", 
              "https://doi.org/10.1038/bjc.2011.458"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10557-009-6181-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013522667", 
              "https://doi.org/10.1007/s10557-009-6181-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2011.427", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010639667", 
              "https://doi.org/10.1038/onc.2011.427"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-005-0059-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001043909", 
              "https://doi.org/10.1007/s00280-005-0059-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.2016.195", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027545802", 
              "https://doi.org/10.1038/bjc.2016.195"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.cdd.4401651", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008951261", 
              "https://doi.org/10.1038/sj.cdd.4401651"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrclinonc.2013.246", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046440165", 
              "https://doi.org/10.1038/nrclinonc.2013.246"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2350-14-26", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025204149", 
              "https://doi.org/10.1186/1471-2350-14-26"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6604865", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024302940", 
              "https://doi.org/10.1038/sj.bjc.6604865"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4939-0437-2_17", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036329887", 
              "https://doi.org/10.1007/978-1-4939-0437-2_17"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13277-014-2007-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013788265", 
              "https://doi.org/10.1007/s13277-014-2007-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd3318", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006829424", 
              "https://doi.org/10.1038/nrd3318"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11154-011-9194-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027694498", 
              "https://doi.org/10.1007/s11154-011-9194-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00392-012-0534-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048188985", 
              "https://doi.org/10.1007/s00392-012-0534-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2407-14-780", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012253784", 
              "https://doi.org/10.1186/1471-2407-14-780"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc2196", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021224284", 
              "https://doi.org/10.1038/nrc2196"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.cdd.4400437", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008917741", 
              "https://doi.org/10.1038/sj.cdd.4400437"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.2856", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015102076", 
              "https://doi.org/10.1038/nm.2856"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2013.34", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035667951", 
              "https://doi.org/10.1038/onc.2013.34"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2407-8-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008000904", 
              "https://doi.org/10.1186/1471-2407-8-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ni.3516", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020677002", 
              "https://doi.org/10.1038/ni.3516"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1039/b809005j", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040175454", 
              "https://doi.org/10.1039/b809005j"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12672-011-0081-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039375158", 
              "https://doi.org/10.1007/s12672-011-0081-7"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2017-02-20", 
        "datePublishedReg": "2017-02-20", 
        "description": "Ultraviolet B (UVB), in addition to having carcinogenic activity, is required for the production of vitamin D3 (D3) in the skin which supplies >90% of the body\u2019s requirement. Vitamin D is activated through hydroxylation by 25-hydroxylases (CYP2R1 or CYP27A1) and 1\u03b1-hydroxylase (CYP27B1) to produce 1,25(OH)2D3, or through the action of CYP11A1 to produce mono-di- and trihydroxy-D3 products that can be further modified by CYP27B1, CYP27A1, and CYP24A1. The active forms of D3, in addition to regulating calcium metabolism, exert pleiotropic activities, which include anticarcinogenic and anti-melanoma effects in experimental models, with photoprotection against UVB-induced damage. These diverse effects are mediated through an interaction with the vitamin D receptor (VDR) and/or as most recently demonstrated through action on retinoic acid orphan receptors (ROR)\u03b1 and ROR\u03b3. With respect to melanoma, low levels of 25(OH)D are associated with thicker tumors and reduced patient survival. Furthermore, single-nucleotide polymorphisms of VDR and the vitamin D-binding protein (VDP) genes affect melanomagenesis or disease outcome. Clinicopathological analyses have shown positive correlation between low or undetectable expression of VDR and/or CYP27B1 in melanoma with tumor progression and shorter overall (OS) and disease-free survival (DFS) times. Paradoxically, this correlation was reversed for CYP24A1 (inactivating 24-hydroxylase), indicating that this enzyme, while inactivating 1,25(OH)2D3, can activate other forms of D3 that are products of the non-canonical pathway initiated by CYP11A1. An inverse correlation has been found between the levels of ROR\u03b1 and ROR\u03b3 expression and melanoma progression and disease outcome. Therefore, we propose that defects in vitamin D signaling including D3 activation/inactivation, and the expression and activity of the corresponding receptors, affect melanoma progression and the outcome of the disease. The existence of multiple bioactive forms of D3 and alternative receptors affecting the behavior of melanoma should be taken into consideration when applying vitamin D management for melanoma therapy.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/labinvest.2017.3", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.4705448", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2725274", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2464643", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5476985", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2465059", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.6721079", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.4714669", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.3804208", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2717710", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2725264", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.4729185", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1017964", 
            "issn": [
              "0023-6837", 
              "1530-0307"
            ], 
            "name": "Laboratory Investigation", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "97"
          }
        ], 
        "keywords": [
          "vitamin D receptor", 
          "vitamin D", 
          "melanoma progression", 
          "disease outcome", 
          "ultraviolet B", 
          "disease-free survival time", 
          "action of CYP11A1", 
          "vitamin D management", 
          "behavior of melanoma", 
          "anti-melanoma effect", 
          "vitamin D signaling", 
          "UVB-induced damage", 
          "patient survival", 
          "retinoic acid orphan receptor", 
          "clinicopathological analysis", 
          "calcium metabolism", 
          "thicker tumors", 
          "shorter overall", 
          "vitamin D3", 
          "D receptor", 
          "survival time", 
          "ROR\u03b3 expression", 
          "D signaling", 
          "melanoma therapy", 
          "alternative receptor", 
          "tumor progression", 
          "melanoma", 
          "non-canonical pathway", 
          "pleiotropic activities", 
          "experimental model", 
          "corresponding receptors", 
          "receptors", 
          "progression", 
          "inverse correlation", 
          "orphan receptor", 
          "single nucleotide polymorphisms", 
          "D3", 
          "carcinogenic activity", 
          "undetectable expression", 
          "body requirements", 
          "CYP27B1", 
          "outcomes", 
          "activation/inactivation", 
          "bioactive form", 
          "diverse effects", 
          "positive correlation", 
          "low levels", 
          "expression", 
          "active form", 
          "CYP24A1", 
          "therapy", 
          "tumors", 
          "CYP27A1", 
          "disease", 
          "ROR\u03b1", 
          "activity", 
          "ROR\u03b3", 
          "Overall", 
          "survival", 
          "CYP11A1", 
          "melanomagenesis", 
          "management", 
          "skin", 
          "levels", 
          "correlation", 
          "metabolism", 
          "action", 
          "signaling", 
          "protein gene", 
          "effect", 
          "polymorphism", 
          "pathway", 
          "damage", 
          "inactivation", 
          "addition", 
          "genes", 
          "role", 
          "enzyme", 
          "hydroxylation", 
          "form", 
          "photoprotection", 
          "D management", 
          "time", 
          "analysis", 
          "production", 
          "products", 
          "consideration", 
          "model", 
          "interaction", 
          "respect", 
          "requirements", 
          "behavior", 
          "existence"
        ], 
        "name": "Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management", 
        "pagination": "706-724", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1083850727"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/labinvest.2017.3"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "28218743"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/labinvest.2017.3", 
          "https://app.dimensions.ai/details/publication/pub.1083850727"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:43", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_750.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/labinvest.2017.3"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/labinvest.2017.3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/labinvest.2017.3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/labinvest.2017.3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/labinvest.2017.3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    403 TRIPLES      21 PREDICATES      157 URIs      121 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/labinvest.2017.3 schema:about N10ed12541cac4123919f084af18e1fcc
    2 N29cb22f6152d4e42b3ce215cef6e59da
    3 N30be5da0bbdc4e3fa92f3251dfa1848a
    4 N4a50a44c375447dc8907decb246ed3c7
    5 N51d20bea40f5418d8116212ee5b88c30
    6 N5ff34d1621274bde814866171a48fadd
    7 N8b9a418cc9704b59834ff2aa07f3637d
    8 Nbf721cd0af704827acbaa523e906c930
    9 Nc2cf4f0da4d54641b21041ac51cdda4b
    10 Nd36b905d3eeb416fb60a90770d700509
    11 Ne4eedf9fa1184ca29aba33d8fb28bfa0
    12 anzsrc-for:11
    13 anzsrc-for:1112
    14 schema:author Nda13f63331304946bdfb6b37ad9b1ae3
    15 schema:citation sg:pub.10.1007/978-1-4939-0437-2_17
    16 sg:pub.10.1007/s00280-005-0059-7
    17 sg:pub.10.1007/s00392-012-0534-1
    18 sg:pub.10.1007/s10557-009-6181-8
    19 sg:pub.10.1007/s11154-011-9194-0
    20 sg:pub.10.1007/s12032-009-9348-z
    21 sg:pub.10.1007/s12672-011-0081-7
    22 sg:pub.10.1007/s13277-014-2007-9
    23 sg:pub.10.1023/a:1008923802001
    24 sg:pub.10.1038/bjc.2011.458
    25 sg:pub.10.1038/bjc.2016.195
    26 sg:pub.10.1038/ni.3516
    27 sg:pub.10.1038/nm.2856
    28 sg:pub.10.1038/nrc2196
    29 sg:pub.10.1038/nrc3691
    30 sg:pub.10.1038/nrclinonc.2013.246
    31 sg:pub.10.1038/nrd3318
    32 sg:pub.10.1038/nrdp.2015.3
    33 sg:pub.10.1038/onc.2011.427
    34 sg:pub.10.1038/onc.2013.34
    35 sg:pub.10.1038/sj.bjc.6604865
    36 sg:pub.10.1038/sj.cdd.4400437
    37 sg:pub.10.1038/sj.cdd.4401651
    38 sg:pub.10.1038/srep14875
    39 sg:pub.10.1039/b809005j
    40 sg:pub.10.1186/1471-2350-14-26
    41 sg:pub.10.1186/1471-2407-14-780
    42 sg:pub.10.1186/1471-2407-8-9
    43 schema:datePublished 2017-02-20
    44 schema:datePublishedReg 2017-02-20
    45 schema:description Ultraviolet B (UVB), in addition to having carcinogenic activity, is required for the production of vitamin D3 (D3) in the skin which supplies >90% of the body’s requirement. Vitamin D is activated through hydroxylation by 25-hydroxylases (CYP2R1 or CYP27A1) and 1α-hydroxylase (CYP27B1) to produce 1,25(OH)2D3, or through the action of CYP11A1 to produce mono-di- and trihydroxy-D3 products that can be further modified by CYP27B1, CYP27A1, and CYP24A1. The active forms of D3, in addition to regulating calcium metabolism, exert pleiotropic activities, which include anticarcinogenic and anti-melanoma effects in experimental models, with photoprotection against UVB-induced damage. These diverse effects are mediated through an interaction with the vitamin D receptor (VDR) and/or as most recently demonstrated through action on retinoic acid orphan receptors (ROR)α and RORγ. With respect to melanoma, low levels of 25(OH)D are associated with thicker tumors and reduced patient survival. Furthermore, single-nucleotide polymorphisms of VDR and the vitamin D-binding protein (VDP) genes affect melanomagenesis or disease outcome. Clinicopathological analyses have shown positive correlation between low or undetectable expression of VDR and/or CYP27B1 in melanoma with tumor progression and shorter overall (OS) and disease-free survival (DFS) times. Paradoxically, this correlation was reversed for CYP24A1 (inactivating 24-hydroxylase), indicating that this enzyme, while inactivating 1,25(OH)2D3, can activate other forms of D3 that are products of the non-canonical pathway initiated by CYP11A1. An inverse correlation has been found between the levels of RORα and RORγ expression and melanoma progression and disease outcome. Therefore, we propose that defects in vitamin D signaling including D3 activation/inactivation, and the expression and activity of the corresponding receptors, affect melanoma progression and the outcome of the disease. The existence of multiple bioactive forms of D3 and alternative receptors affecting the behavior of melanoma should be taken into consideration when applying vitamin D management for melanoma therapy.
    46 schema:genre article
    47 schema:isAccessibleForFree true
    48 schema:isPartOf N2656b733f2b047408e397d30b396492a
    49 N338d1a20e75f47328db003d7a3d945fb
    50 sg:journal.1017964
    51 schema:keywords CYP11A1
    52 CYP24A1
    53 CYP27A1
    54 CYP27B1
    55 D management
    56 D receptor
    57 D signaling
    58 D3
    59 Overall
    60 RORα
    61 RORγ
    62 RORγ expression
    63 UVB-induced damage
    64 action
    65 action of CYP11A1
    66 activation/inactivation
    67 active form
    68 activity
    69 addition
    70 alternative receptor
    71 analysis
    72 anti-melanoma effect
    73 behavior
    74 behavior of melanoma
    75 bioactive form
    76 body requirements
    77 calcium metabolism
    78 carcinogenic activity
    79 clinicopathological analysis
    80 consideration
    81 correlation
    82 corresponding receptors
    83 damage
    84 disease
    85 disease outcome
    86 disease-free survival time
    87 diverse effects
    88 effect
    89 enzyme
    90 existence
    91 experimental model
    92 expression
    93 form
    94 genes
    95 hydroxylation
    96 inactivation
    97 interaction
    98 inverse correlation
    99 levels
    100 low levels
    101 management
    102 melanoma
    103 melanoma progression
    104 melanoma therapy
    105 melanomagenesis
    106 metabolism
    107 model
    108 non-canonical pathway
    109 orphan receptor
    110 outcomes
    111 pathway
    112 patient survival
    113 photoprotection
    114 pleiotropic activities
    115 polymorphism
    116 positive correlation
    117 production
    118 products
    119 progression
    120 protein gene
    121 receptors
    122 requirements
    123 respect
    124 retinoic acid orphan receptor
    125 role
    126 shorter overall
    127 signaling
    128 single nucleotide polymorphisms
    129 skin
    130 survival
    131 survival time
    132 therapy
    133 thicker tumors
    134 time
    135 tumor progression
    136 tumors
    137 ultraviolet B
    138 undetectable expression
    139 vitamin D
    140 vitamin D management
    141 vitamin D receptor
    142 vitamin D signaling
    143 vitamin D3
    144 schema:name Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management
    145 schema:pagination 706-724
    146 schema:productId Nda8a1a5e464a4cf1b5b4d4068d7d4d42
    147 Ndf257b41c59440ec884a245e639bb3b1
    148 Ne73be9b9505d4703968a2098dc1330b2
    149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083850727
    150 https://doi.org/10.1038/labinvest.2017.3
    151 schema:sdDatePublished 2022-10-01T06:43
    152 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    153 schema:sdPublisher Nebb61efc181c4622bd79111af2deb654
    154 schema:url https://doi.org/10.1038/labinvest.2017.3
    155 sgo:license sg:explorer/license/
    156 sgo:sdDataset articles
    157 rdf:type schema:ScholarlyArticle
    158 N10ed12541cac4123919f084af18e1fcc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Melanoma
    160 rdf:type schema:DefinedTerm
    161 N12dd562db90240a895d692129727a305 rdf:first sg:person.01173540763.45
    162 rdf:rest N309f7039f0bc4a1182a9303b03a67961
    163 N1da7e9b7d88547bd8b2641363f62a4e4 rdf:first sg:person.01247433576.16
    164 rdf:rest N229dfab56c0e42f3abc6440371a9535e
    165 N229dfab56c0e42f3abc6440371a9535e rdf:first sg:person.01357647717.25
    166 rdf:rest N12dd562db90240a895d692129727a305
    167 N2656b733f2b047408e397d30b396492a schema:volumeNumber 97
    168 rdf:type schema:PublicationVolume
    169 N29cb22f6152d4e42b3ce215cef6e59da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Receptors, Calcitriol
    171 rdf:type schema:DefinedTerm
    172 N309f7039f0bc4a1182a9303b03a67961 rdf:first sg:person.0603130014.84
    173 rdf:rest N6ebf658dc8c34450bb22d345a791da8d
    174 N30be5da0bbdc4e3fa92f3251dfa1848a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Ultraviolet Rays
    176 rdf:type schema:DefinedTerm
    177 N338d1a20e75f47328db003d7a3d945fb schema:issueNumber 6
    178 rdf:type schema:PublicationIssue
    179 N4a50a44c375447dc8907decb246ed3c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Vitamin D
    181 rdf:type schema:DefinedTerm
    182 N51d20bea40f5418d8116212ee5b88c30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Disease Progression
    184 rdf:type schema:DefinedTerm
    185 N5ff34d1621274bde814866171a48fadd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Animals
    187 rdf:type schema:DefinedTerm
    188 N6ebf658dc8c34450bb22d345a791da8d rdf:first sg:person.0771044716.53
    189 rdf:rest N7e3a4887a4ed4de88858bd68e4561282
    190 N7e3a4887a4ed4de88858bd68e4561282 rdf:first sg:person.01205643625.44
    191 rdf:rest Nce6477aa83344523bd80971122e91cd7
    192 N8b9a418cc9704b59834ff2aa07f3637d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Mice
    194 rdf:type schema:DefinedTerm
    195 Nbf721cd0af704827acbaa523e906c930 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    196 schema:name Signal Transduction
    197 rdf:type schema:DefinedTerm
    198 Nc2cf4f0da4d54641b21041ac51cdda4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Humans
    200 rdf:type schema:DefinedTerm
    201 Nce6477aa83344523bd80971122e91cd7 rdf:first sg:person.01213437447.92
    202 rdf:rest rdf:nil
    203 Nd36b905d3eeb416fb60a90770d700509 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Cytochrome P-450 Enzyme System
    205 rdf:type schema:DefinedTerm
    206 Nda13f63331304946bdfb6b37ad9b1ae3 rdf:first sg:person.016612034677.24
    207 rdf:rest N1da7e9b7d88547bd8b2641363f62a4e4
    208 Nda8a1a5e464a4cf1b5b4d4068d7d4d42 schema:name dimensions_id
    209 schema:value pub.1083850727
    210 rdf:type schema:PropertyValue
    211 Ndf257b41c59440ec884a245e639bb3b1 schema:name doi
    212 schema:value 10.1038/labinvest.2017.3
    213 rdf:type schema:PropertyValue
    214 Ne4eedf9fa1184ca29aba33d8fb28bfa0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    215 schema:name Epidermis
    216 rdf:type schema:DefinedTerm
    217 Ne73be9b9505d4703968a2098dc1330b2 schema:name pubmed_id
    218 schema:value 28218743
    219 rdf:type schema:PropertyValue
    220 Nebb61efc181c4622bd79111af2deb654 schema:name Springer Nature - SN SciGraph project
    221 rdf:type schema:Organization
    222 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    223 schema:name Medical and Health Sciences
    224 rdf:type schema:DefinedTerm
    225 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    226 schema:name Oncology and Carcinogenesis
    227 rdf:type schema:DefinedTerm
    228 sg:grant.2464643 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    229 rdf:type schema:MonetaryGrant
    230 sg:grant.2465059 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    231 rdf:type schema:MonetaryGrant
    232 sg:grant.2717710 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    233 rdf:type schema:MonetaryGrant
    234 sg:grant.2725264 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    235 rdf:type schema:MonetaryGrant
    236 sg:grant.2725274 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    237 rdf:type schema:MonetaryGrant
    238 sg:grant.3804208 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    239 rdf:type schema:MonetaryGrant
    240 sg:grant.4705448 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    241 rdf:type schema:MonetaryGrant
    242 sg:grant.4714669 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    243 rdf:type schema:MonetaryGrant
    244 sg:grant.4729185 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    245 rdf:type schema:MonetaryGrant
    246 sg:grant.5476985 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    247 rdf:type schema:MonetaryGrant
    248 sg:grant.6721079 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2017.3
    249 rdf:type schema:MonetaryGrant
    250 sg:journal.1017964 schema:issn 0023-6837
    251 1530-0307
    252 schema:name Laboratory Investigation
    253 schema:publisher Springer Nature
    254 rdf:type schema:Periodical
    255 sg:person.01173540763.45 schema:affiliation grid-institutes:grid.411797.d
    256 schema:familyName Jóźwicki
    257 schema:givenName Wojciech
    258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173540763.45
    259 rdf:type schema:Person
    260 sg:person.01205643625.44 schema:affiliation grid-institutes:grid.1012.2
    261 schema:familyName Tuckey
    262 schema:givenName Robert C
    263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205643625.44
    264 rdf:type schema:Person
    265 sg:person.01213437447.92 schema:affiliation grid-institutes:grid.265892.2
    266 schema:familyName Elmets
    267 schema:givenName Craig A
    268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213437447.92
    269 rdf:type schema:Person
    270 sg:person.01247433576.16 schema:affiliation grid-institutes:grid.411797.d
    271 schema:familyName Brożyna
    272 schema:givenName Anna A
    273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247433576.16
    274 rdf:type schema:Person
    275 sg:person.01357647717.25 schema:affiliation grid-institutes:grid.11451.30
    276 schema:familyName Zmijewski
    277 schema:givenName Michal A
    278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357647717.25
    279 rdf:type schema:Person
    280 sg:person.016612034677.24 schema:affiliation grid-institutes:grid.280808.a
    281 schema:familyName Slominski
    282 schema:givenName Andrzej T
    283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016612034677.24
    284 rdf:type schema:Person
    285 sg:person.0603130014.84 schema:affiliation grid-institutes:grid.280664.e
    286 schema:familyName Jetten
    287 schema:givenName Anton M
    288 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603130014.84
    289 rdf:type schema:Person
    290 sg:person.0771044716.53 schema:affiliation grid-institutes:grid.1013.3
    291 schema:familyName Mason
    292 schema:givenName Rebecca S
    293 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771044716.53
    294 rdf:type schema:Person
    295 sg:pub.10.1007/978-1-4939-0437-2_17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036329887
    296 https://doi.org/10.1007/978-1-4939-0437-2_17
    297 rdf:type schema:CreativeWork
    298 sg:pub.10.1007/s00280-005-0059-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001043909
    299 https://doi.org/10.1007/s00280-005-0059-7
    300 rdf:type schema:CreativeWork
    301 sg:pub.10.1007/s00392-012-0534-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048188985
    302 https://doi.org/10.1007/s00392-012-0534-1
    303 rdf:type schema:CreativeWork
    304 sg:pub.10.1007/s10557-009-6181-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013522667
    305 https://doi.org/10.1007/s10557-009-6181-8
    306 rdf:type schema:CreativeWork
    307 sg:pub.10.1007/s11154-011-9194-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027694498
    308 https://doi.org/10.1007/s11154-011-9194-0
    309 rdf:type schema:CreativeWork
    310 sg:pub.10.1007/s12032-009-9348-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1016315086
    311 https://doi.org/10.1007/s12032-009-9348-z
    312 rdf:type schema:CreativeWork
    313 sg:pub.10.1007/s12672-011-0081-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039375158
    314 https://doi.org/10.1007/s12672-011-0081-7
    315 rdf:type schema:CreativeWork
    316 sg:pub.10.1007/s13277-014-2007-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013788265
    317 https://doi.org/10.1007/s13277-014-2007-9
    318 rdf:type schema:CreativeWork
    319 sg:pub.10.1023/a:1008923802001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030296825
    320 https://doi.org/10.1023/a:1008923802001
    321 rdf:type schema:CreativeWork
    322 sg:pub.10.1038/bjc.2011.458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025567432
    323 https://doi.org/10.1038/bjc.2011.458
    324 rdf:type schema:CreativeWork
    325 sg:pub.10.1038/bjc.2016.195 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027545802
    326 https://doi.org/10.1038/bjc.2016.195
    327 rdf:type schema:CreativeWork
    328 sg:pub.10.1038/ni.3516 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020677002
    329 https://doi.org/10.1038/ni.3516
    330 rdf:type schema:CreativeWork
    331 sg:pub.10.1038/nm.2856 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015102076
    332 https://doi.org/10.1038/nm.2856
    333 rdf:type schema:CreativeWork
    334 sg:pub.10.1038/nrc2196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021224284
    335 https://doi.org/10.1038/nrc2196
    336 rdf:type schema:CreativeWork
    337 sg:pub.10.1038/nrc3691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052056915
    338 https://doi.org/10.1038/nrc3691
    339 rdf:type schema:CreativeWork
    340 sg:pub.10.1038/nrclinonc.2013.246 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046440165
    341 https://doi.org/10.1038/nrclinonc.2013.246
    342 rdf:type schema:CreativeWork
    343 sg:pub.10.1038/nrd3318 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006829424
    344 https://doi.org/10.1038/nrd3318
    345 rdf:type schema:CreativeWork
    346 sg:pub.10.1038/nrdp.2015.3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045528904
    347 https://doi.org/10.1038/nrdp.2015.3
    348 rdf:type schema:CreativeWork
    349 sg:pub.10.1038/onc.2011.427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010639667
    350 https://doi.org/10.1038/onc.2011.427
    351 rdf:type schema:CreativeWork
    352 sg:pub.10.1038/onc.2013.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035667951
    353 https://doi.org/10.1038/onc.2013.34
    354 rdf:type schema:CreativeWork
    355 sg:pub.10.1038/sj.bjc.6604865 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024302940
    356 https://doi.org/10.1038/sj.bjc.6604865
    357 rdf:type schema:CreativeWork
    358 sg:pub.10.1038/sj.cdd.4400437 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008917741
    359 https://doi.org/10.1038/sj.cdd.4400437
    360 rdf:type schema:CreativeWork
    361 sg:pub.10.1038/sj.cdd.4401651 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008951261
    362 https://doi.org/10.1038/sj.cdd.4401651
    363 rdf:type schema:CreativeWork
    364 sg:pub.10.1038/srep14875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027641851
    365 https://doi.org/10.1038/srep14875
    366 rdf:type schema:CreativeWork
    367 sg:pub.10.1039/b809005j schema:sameAs https://app.dimensions.ai/details/publication/pub.1040175454
    368 https://doi.org/10.1039/b809005j
    369 rdf:type schema:CreativeWork
    370 sg:pub.10.1186/1471-2350-14-26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025204149
    371 https://doi.org/10.1186/1471-2350-14-26
    372 rdf:type schema:CreativeWork
    373 sg:pub.10.1186/1471-2407-14-780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012253784
    374 https://doi.org/10.1186/1471-2407-14-780
    375 rdf:type schema:CreativeWork
    376 sg:pub.10.1186/1471-2407-8-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008000904
    377 https://doi.org/10.1186/1471-2407-8-9
    378 rdf:type schema:CreativeWork
    379 grid-institutes:grid.1012.2 schema:alternateName School of Chemistry and Biochemistry, The University of Western Australia, Crawley, Perth, WA, Australia
    380 schema:name School of Chemistry and Biochemistry, The University of Western Australia, Crawley, Perth, WA, Australia
    381 rdf:type schema:Organization
    382 grid-institutes:grid.1013.3 schema:alternateName Bosch Institute and School of Medical Sciences, Sydney Medical School, The University of Sydney, Sydney, Australia
    383 schema:name Bosch Institute and School of Medical Sciences, Sydney Medical School, The University of Sydney, Sydney, Australia
    384 rdf:type schema:Organization
    385 grid-institutes:grid.11451.30 schema:alternateName Department of Histology, Medical University of Gdańsk, Poland
    386 schema:name Department of Histology, Medical University of Gdańsk, Poland
    387 rdf:type schema:Organization
    388 grid-institutes:grid.265892.2 schema:alternateName Comprehensive Cancer Center, Cancer Chemoprevention Program, and Nutrition Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL, USA
    389 schema:name Comprehensive Cancer Center, Cancer Chemoprevention Program, and Nutrition Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL, USA
    390 Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA
    391 rdf:type schema:Organization
    392 grid-institutes:grid.280664.e schema:alternateName Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA
    393 schema:name Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA
    394 rdf:type schema:Organization
    395 grid-institutes:grid.280808.a schema:alternateName Pathology and Laboratory Medicine, VA Medical Center, Birmingham, AL, USA
    396 schema:name Comprehensive Cancer Center, Cancer Chemoprevention Program, and Nutrition Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL, USA
    397 Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA
    398 Pathology and Laboratory Medicine, VA Medical Center, Birmingham, AL, USA
    399 rdf:type schema:Organization
    400 grid-institutes:grid.411797.d schema:alternateName Department of Tumor Pathology and Pathomorphology, Faculty of Health Sciences, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
    401 schema:name Department of Tumor Pathology and Pathomorphology, Faculty of Health Sciences, Nicolaus Copernicus University Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
    402 Department of Tumor Pathology and Pathomorphology, Oncology Centre - Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland
    403 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...